CDY1B

Q-omics provides the consensus-scored CDY1B profile across patient tissues and cancer cell-line models. CDY1B expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in LAML. Additionally, CDY1B RNA expression shows 212 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight LAML, and ESCA as cancer lineages where CDY1B shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes CDY1B survival associations across molecular data types. CDY1B RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

CDY1B data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	LAML (36)	view →

This table ranks reproducible CDY1B RNA expression–survival associations across cancer types. High CDY1B expression shows unfavorable associations in LAML. The LAML Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .034). Together, the overview and detailed table identify LAML as the clearest survival context for CDY1B RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Tertile	All	0.165	0.581	.034	36	view →

Pink = unfavorable, green = favorable. all 1 lineages →

CDY1B-LAML (DFS)

Explore this curve interactively →